- Home
- QNME vs MODD Comparison
QNME vs MODD Comparison
Compare QNME & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$0.48
HOLD
Current Price
$1.96
Company Overview
Basic Information| Metric | QNME | MODD |
|---|---|---|
| Founded | 2018 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Integrated Freight & Logistics | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4M | 11.2M |
| IPO Year | 2024 | 2019 |
Fundamental Metrics
Financial Performance| Metric | QNME | MODD |
|---|---|---|
| Price | $0.48 | $1.96 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 7.4M | 126.7K |
| Earning Date | 11-18-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 47.83 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $5,850,681.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 111.79 | N/A |
| 52 Week Low | $0.26 | $0.12 |
| 52 Week High | $1.40 | $6.16 |
Technical Indicators
Market Signals| Indicator | QNME | MODD |
|---|---|---|
| Relative Strength Index (RSI) | 47.78 | 44.88 |
| Support Level | $0.50 | $1.77 |
| Resistance Level | $0.94 | $2.49 |
| Average True Range (ATR) | 0.10 | 0.38 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 6.26 | 34.62 |
Price Performance
Historical Comparison QNME
MODD
About QNME Quanome Technologies Inc. Common Stock
Quanome Technologies Inc is a U.S.-based integrated cross-border supply chain solution provider with a strategic focus on the Asian market including China and South Korea.
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, marketing and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.